COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017

Nov 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-11-17

Reporting Person: Fleming Alison B (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-17	Common Stock	M	1950	$.28	Acquired	28513	Direct
2017-11-17	Common Stock	S	1950	$17.00	Disposed	26563	Direct
2017-11-17	Common Stock	M	1239	$.28	Acquired	27802	Direct
2017-11-17	Common Stock	S	1239	$17.00	Disposed	26563	Direct
2017-11-17	Common Stock	S	840	$17.00	Disposed	25723	Direct
2017-11-21	Common Stock	M	572	$.28	Acquired	26295	Direct
2017-11-21	Common Stock	S	572	$19.00	Disposed	25723	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-17	Stock option (right to purchase)	$.28	M	1950	Disposed	2024-03-05	Common Stock (1950)	Direct
2017-11-17	Stock option (right to purchase)	$.28	M	1239	Disposed	2024-03-05	Common Stock (1239)	Direct
2017-11-21	Stock option (right to purchase)	$.28	M	572	Disposed	2024-03-05	Common Stock (572)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

F2: 2,600 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vests and becomes exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer.

F3: 2,410 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vests and becomes exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.